Defunct Company
Total Trials
15
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,272
NCT02587364
Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 1999
Completion: Sep 30, 1999
NCT02585869
Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides
Phase: Phase 2
Start: Dec 31, 1999
Completion: Jun 30, 2001
NCT02587390
Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers
Start: May 31, 2000
Completion: Jul 31, 2000
NCT02571257
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy
Start: Aug 31, 2000
Completion: Apr 30, 2002
NCT02586168
The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects
Start: Jul 31, 2001
Completion: Oct 31, 2001
NCT02587416
Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers
Start: Nov 30, 2002
Completion: Dec 31, 2002
NCT02591836
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin
Start: Jan 31, 2003
Completion: Jun 30, 2003
NCT01822925
Study of DA-9801 to Treat Diabetic Neuropathy
Start: Nov 30, 2013
Completion: Jan 31, 2015
NCT02722408
Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)
Start: Jun 30, 2016
Completion: Jul 31, 2017
NCT02634151
A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
Start: Nov 30, 2016
Completion: Aug 31, 2017
NCT02944383
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia
Start: Dec 31, 2016
Completion: May 9, 2018
NCT04603924
Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients
Phase: Phase 2/3
Start: Oct 7, 2020
Completion: Feb 16, 2022
NCT04705415
A Single and Multiple Ascending Dose Study of Niclosamide in Healthy Volunteers
Start: Nov 17, 2020
Completion: Oct 28, 2022
NCT06054815
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Start: Sep 14, 2023
Completion: Oct 30, 2024
NCT06252220
First in Human Study in Subjects With Obesity, But Otherwise Healthy
Start: Mar 25, 2024
Completion: Mar 31, 2026